Search

This study examined the operational strategies of Beijing Time Fengjun Entertainment in the Chinese market. Using the Marketing Mix Theory, it analysed Time Fengjun’s promotion, product, and place strategies. Effective promotion, high-quality products, and diverse marketing channels were found to positively influence consumer purchasing intent. The research focused on understanding the factors driving Time Fengjun’s success. It provided valuable insights for entertainment companies operating in China, aiding in the formulation of effective strategies. Multiple sources, including academic papers, industry reports, and case studies, support the research findings. The analysis confirmed that Time Fengjun’s success stems from its effective promotions, high-quality products, and diverse marketing channels. They serve as a roadmap for other companies seeking success in the dynamic Chinese entertainment industry. The study’s implications were relevant to entertainment companies aiming to enter or expand in China. Understanding the identified success factors enables the development of strategies to navigate the market and increase the likelihood of success. In conclusion, this study unveils the operational strategies of Beijing Time Fengjun Entertainment and highlights the key factors driving its success. It offered actionable insights for entertainment companies operating in China.

Background Primary prevention of cardiovascular disease (CVD) requires adequate control of hypertension and diabetes. We designed and implemented pharmaceutical and healthy lifestyle interventions for patients with diabetes and/or hypertension in rural primary care, and assessed their effectiveness at reducing severe CVD events. Methods and findings We used a pragmatic, parallel group, 2-arm, controlled, superiority, cluster trial design. We randomised 67 township hospitals in Zhejiang Province, China, to intervention (34) or control (33). A total of 31,326 participants were recruited, with 15,380 in the intervention arm and 15,946 in the control arm. Participants had no known CVD and were either patients with hypertension and a 10-year CVD risk of 20% or higher, or patients with type 2 diabetes regardless of their CVD risk. The intervention included prescription of a standardised package of medicines, individual advice on lifestyle change, and adherence support. Control was usual hypertension and diabetes care. In both arms, as usual in China, most outpatient drug costs were out of pocket. The primary outcome was severe CVD events, including coronary heart disease and stroke, during 36 months of follow-up, as recorded by the CVD surveillance system. The study was implemented between December 2013 and May 2017. A total of 13,385 (87%) and 14,745 (92%) participated in the intervention and control arms, respectively. Their mean age was 64 years, 51% were women, and 90% were farmers. Of all participants, 64% were diagnosed with hypertension with or without diabetes, and 36% were diagnosed with diabetes only. All township hospitals and participants completed the 36-month follow-up. At 36 months, there were 762 and 874 severe CVD events in the intervention and control arms, respectively, yielding a non-significant effect on CVD incidence rate (1.92 and 2.01 per 100 person-years, respectively; crude incidence rate ratio = 0.90 [95% CI: 0.74, 1.08; P = 0.259]). We observed significant, but small, differences in the change from baseline to follow-up for systolic blood pressure (-1.44 mm Hg [95% CI: -2.26, -0.62; P < 0.001]) and diastolic blood pressure (-1.29 mm Hg [95% CI: -1.77, -0.80; P < 0.001]) in the intervention arm compared to the control arm. Self-reported adherence to recommended medicines was significantly higher in the intervention arm compared with the control arm at 36 months. No safety concerns were identified. Main study limitations include all participants being informed about their high CVD risk at baseline, non-blinding of participants, and the relatively short follow-up period available for judging potential changes in rates of CVD events. Conclusions The comprehensive package of pharmaceutical and healthy lifestyle interventions did not reduce severe CVD events over 36 months. Improving health system factors such as universal coverage for the cost of essential medicines is required for successful risk-based CVD prevention programmes. Trial registration ISRCTN registry ISRCTN58988083., Author(s): Xiaolin Wei 1, Zhitong Zhang 1, Marc K. C. Chong 2, Joseph P. Hicks 3, Weiwei Gong 4, Guanyang Zou 5, Jieming Zhong 4, John D. Walley 3, Ross [...]

Based on the matching data of China Industrial Enterprise Database and China Customs Database from 2000 to 2015, this paper examines the influence of robot application (RA) on the export product scope (EPS) of multi-product enterprises (MPEs), the influence channels, and the export competition strategies of these enterprises. The research results show that RA has promoted the expansion of EPS of MPEs, and this promotion effect is prominent especially for the export of labor-intensive products, resource-intensive products and for non-state-owned enterprises (SOEs). The adjustment of EPS by RA not only enhances efficiency through productivity improvement effect and cost-saving effect, but also improves quality through emission-reduction effect and product quality effect, which is very obvious in long-quality-ladder enterprises. The RA-expanded product scope covers both old products and new products manufactured in the same industry. Facing fierce competition in the same industry, robot-using enterprises prefer quality competition strategy, which further promotes the expansion of EPS. [ABSTRACT FROM AUTHOR]

Background Inappropriate antibiotic prescribing causes widespread serious health problems. To reduce prescribing of antibiotics in Chinese primary care to children with upper respiratory tract infections (URTIs), we developed an intervention comprising clinical guidelines, monthly prescribing review meetings, doctor-patient communication skills training, and education materials for caregivers. We previously evaluated our intervention using an unblinded cluster-randomised controlled trial (cRCT) in 25 primary care facilities across two rural counties. When our trial ended at the 6-month follow-up period, we found that the intervention had reduced antibiotic prescribing for childhood URTIs by 29 percentage points (pp) (95% CI -42 to -16). Methods and findings In this long-term follow-up study, we collected our trial outcomes from the one county (14 facilities and 1:1 cluster randomisation ratio) that had electronic records available 12 months after the trial ended, at the 18-month follow-up period. Our primary outcome was the antibiotic prescription rate (APR)-the percentage of outpatient prescriptions containing any antibiotic(s) for children aged 2 to 14 years who had a primary diagnosis of a URTI and had no other illness requiring antibiotics. We also conducted 15 in-depth interviews to understand how interventions were sustained. In intervention facilities, the APR was 84% (1,171 out of 1,400) at baseline, 37% (515 out of 1,380) at 6 months, and 54% (2,748 out of 5,084) at 18 months, and in control facilities, it was 76% (1,063 out of 1,400), 77% (1,084 out of 1,400), and 75% (2,772 out of 3,685), respectively. After adjusting for patient and prescribing doctor covariates, compared to the baseline intervention-control difference, the difference at 6 months represented a 6-month intervention-arm reduction in the APR of -49 pp (95% CI -63 to -35; P < 0.0001), and compared to the baseline difference, the difference at 18 months represented an 18-month intervention-arm reduction in the APR of -36 pp (95% CI -55 to -17; P < 0.0001). Compared to the 6-month intervention-control difference, the difference at 18 months represented no change in the APR: 13 pp (95% CI -7 to 33; P = 0.21). Factors reported to sustain reductions in antibiotic prescribing included doctors' improved knowledge and communication skills and focused prescription review meetings, whereas lack of supervision and monitoring may be associated with relapse. Key limitations were not including all clusters from the trial and not collecting returned visits or sepsis cases. Conclusions Our intervention was associated with sustained and substantial reductions in antibiotic prescribing at the end of the intervention period and 12 months later. Our intervention may be adapted to similar resource-poor settings. Trial registration ISRCTN registry ISRCTN14340536., Author(s): Xiaolin Wei 1, Zhitong Zhang 2, Joseph P. Hicks 3, John D. Walley 3, Rebecca King 3, James N. Newell 3, Jia Yin 4,5, Jun Zeng 6, Yan Guo [...]